Veracyte (VCYT) Tops Q2 EPS by 11c; Offers Guidance

Veracyte (NASDAQ: VCYT) reported Q2 EPS of $0.54, $0.11 better than the analyst estimate of $0.43. Revenue for the quarter came in at $150.32 million versus the consensus estimate of $144.56 million.

GUIDANCE:

Veracyte sees FY2026 revenue of $590-596 million, versus the consensus of $585.5 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Holcim to acquire Fermacell from James Hardie for EUR 840M
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance